Product logins

Find logins to all Clarivate products below.


Obesity Interventions | Market Insights | US | 2019

The US market for obesity interventions will grow moderately through 2027, driven by an increasing obese population and penetration of bariatric procedures due to positive clinical trials and improvements in insurance coverage.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the obesity intervention market in the US across a 10-year period.

Related Medtech Insights Reports

Report
Obesity Interventions – Market Insights – United States
The rise of GLP-1 receptor agonists is significantly transforming the landscape of obesity treatment, impacting the growth of bariatric procedures and affecting device sales. Innovations and future…
Report
Obesity Interventions | Market Insights | US | 2024
The US obesity intervention device market will show modest growth over the forecast period. Rising use of GLP-1 receptor agonists for obesity treatment will temporarily slow the growth of bariatric…
Report
Obesity Interventions | Market Insights | US | 2023
Procedure deferrals due to the COVID-19 pandemic severely impacted the US obesity intervention market in 2020, and the elective nature of many postponed procedures hindered the pace of recovery…
Report
Deep Venous Disease Treatment Devices | Market Insights | Global | 2020
The global market for deep venous disease treatment devices consists of a combination of the mature deep venous disease treatment thrombectomy and thrombolysis and PTA balloon catheter segments,…
Report
Peripheral Vascular Devices | Market Insights | Japan | 2020
The Japanese PV device market will see modest growth through 2028, driven primarily by the expanding PAD population and the availability of new premium-priced products, such as DES and …